Róisín Shortall
Question:880. Deputy Róisín Shortall asked the Minister for Health the steps he is taking to improve detection, diagnosis and treatment of ovarian cancer; and if he will make a statement on the matter. [45139/20]
View answerWednesday, 13 January 2021
Questions (880)
Written answers
The HSE's National Cancer Control Programme, in conjunction with the National Clinical Effectiveness Committee, published a National Clinical Guideline on Ovarian Cancer in August 2019. The guideline is based on best research evidence, in conjunction with clinical expertise and patient preferences, and was developed using a clear evidence-based methodology that is used internationally.
The overall objectives of the National Clinical Guideline on Ovarian Cancer are:
- to improve the quality of clinical care, improving patient outcomes by reducing morbidity and mortality;
- to reduce variation in practice and improve consistency and standards of care by promoting interventions of proven benefit - and discouraging ineffective ones; and
- to address areas of clinical care with new and emerging evidence.
A total of €20m additional funding has been allocated for the National Cancer Strategy in 2021. The 2021 funding will facilitate significant progression of key priorities of the National Cancer Strategy, including prevention measures, improved access to diagnostics, the further development of medical, radiation and surgical oncology and expanded services to support those living with and beyond cancer.